<DOC>
	<DOCNO>NCT00745056</DOCNO>
	<brief_summary>This prospective , observational study cohort old post-menopausal participant WHI Memory Study , sub-cohort participant WHI Hormone Trials . Annual cognitive assessment ascertainment cognitive impairment enable continued monitor long-term effect randomization HT cognition identification predictor cognitive vulnerability resilience old woman .</brief_summary>
	<brief_title>Examining Relationship Between Hormone Therapy ( HT ) Cognitive Function ( The WHIMS-ECHO Study )</brief_title>
	<detailed_description>Identification predictor cognitive impairment cognitive resilience among age woman important incidence mild cognitive impairment ( MCI ) dementia increase age woman live long . The Women 's Health Initiative Memory Study examine impact randomization hormone therapy ( conjugated equine estrogen alone combination medroxyprogesterone vs. placebo ) subset participant age 65-79 year enrollment WHI WHI Hormone Trials . WHIMS reveal increase risk all-cause dementia MCI plus poor global cognitive function among woman randomize HT compare receive placebo . WHIMS ECHO prospective , observational study remain cohort WHIMS participant follow cessation treatment . Annual cognitive assessment learn , attention , memory , work memory , executive function language conduct telephone trained staff adjudication incident cognitive impairment ( MCI dementia ) continue . This enable continued monitor long-term effect randomization HT cognition identification predictor cognitive age resilience old woman .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<criteria>Participated WHIMS study Exclusion Criteria NonEnglish speak Hearing Impaired</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Memory</keyword>
	<keyword>Hormone Therapy</keyword>
	<keyword>HT</keyword>
</DOC>